Similar articles

• Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.

  Jones PH, Hunninghake DB, Ferdinand KC, Stein EA, Gold A, Caplan RJ, Blasetto JW; Statin Therapies for Elevated Lipid Levels Compared Across Doses to Rosuvastatin Study Group. Jones PH, et al. Clin Ther. 2004 Sep;26(9):1388-99. doi: 10.1016/j.clinthera.2004.09.006. Clin Ther. 2004. PMID: 15531001 Clinical Trial.
• Effects of switching statins on achievement of lipid goals: Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) study.

  Schuster H, Barter PJ, Stender S, Cheung RC, Bonnet J, Morrell JM, Watkins C, Kallend D, Raza A; Effective Reductions in Cholesterol Using Rosuvastatin Therapy I study group. Schuster H, et al. Am Heart J. 2004 Apr;147(4):705-13. doi: 10.1016/j.ahj.2003.10.004. Am Heart J. 2004. PMID: 15077101 Clinical Trial.
• [For coronary disease patients is certain: the lower the LDL the better].

  [No authors listed] [No authors listed] MMW Fortschr Med. 2006 Jun 15;148(24):6. MMW Fortschr Med. 2006. PMID: 16850797 German. No abstract available.
• Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.

  Daskalopoulou SS, Mikhailidis DP. Daskalopoulou SS, et al. Curr Med Res Opin. 2006 Mar;22(3):511-28. doi: 10.1185/030079906X89856. Curr Med Res Opin. 2006. PMID: 16574035 Review.
• [Primary and secondary prevention of coronary disease by statins].

  Ferrières J. Ferrières J. Ann Cardiol Angeiol (Paris). 1999 Feb;48(2):128-36. Ann Cardiol Angeiol (Paris). 1999. PMID: 12555337 Review. French.